Characterization of the Potent Gonadotropin-Releasing Activity of RF9, a Selective Antagonist of RF-Amide-Related Peptides and Neuropeptide FF Receptors: Physiological and Pharmacological Implications
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Identification of RF-amide-related peptides (RFRP), as putative mammalian orthologs of the avian gonadotropin-inhibitory hormone, has drawn considerable interest on its potential effects and mechanisms of action in the control of gonadotropin secretion in higher vertebrates. Yet, these analyses have so far relied mostly on indirect approaches, while direct assessment of their physiological roles has been hampered by the lack of suitable antagonists. RF9 was recently reported as a selective and potent antagonist of the receptors for RFRP (RFRPR) and the related neuropeptides, neuropeptide FF (NPFF) and neuropeptide AF (NPFF receptor). We show here that RF9 possesses very strong gonadotropin-releasing activities in vivo. Central administration of RF9 evoked a dose-dependent increase of LH and FSH levels in adult male and female rats. Similarly, male and female mice responded to intracerebroventricular injection of RF9 with robust LH secretory bursts. In rats, administration of RF9 further augmented the gonadotropin-releasing effects of kisspeptin, and its stimulatory effects were detected despite the prevailing suppression of gonadotropin secretion by testosterone or estradiol. In fact, blockade of estrogen receptor-α partially attenuated gonadotropin responses to RF9. Finally, systemic administration of RF9 modestly stimulated LH secretion in vivo, although no direct effects in terms of gonadotropin secretion were detected at the pituitary in vitro. Altogether, these data are the first to disclose the potent gonadotropin-releasing activity of RF9, a selective antagonist of RFRP (and NPFF) receptors. Our findings support a putative role of the RFRP/gonadotropin-inhibitory hormone system in the central control of gonadotropin secretion in mammals and have interesting implications concerning the potential therapeutic indications and pharmacological effects of RF9.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification and characterization of a gonadotropin-inhibitory system in the brains of mammals
Kriegsfeld, L. J., Mei, D. F., Bentley, G. E., Ubuka, T., Mason, A. O., Inoue, K., Ukena, K., Tsutsui, K., & Silver, R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511003103 · Cited by 552
Navarro, V. M., Castellano, J. M., Fernández-Fernández, R., Tovar, S., Roa, J., Mayen, A., Nogueiras, R., Vazquez, M. J., Barreiro, M. L., Magni, P., et al. (2005) · Endocrinology · doi:10.1210/en.2004-0836 · Cited by 449 · cited 3×
“As a general procedure, and to target central neuroendocrine pathways, a protocol of intracerebroventricular (icv) injection of RF9 was implemented, as described in detail elsewhere (34, 35).”
MethodResultSelf-citationSmith, J. T., Coolen, L. M., Kriegsfeld, L. J., Sari, I. P., Jaafarzadehshirazi, M. R., Maltby, M., Bateman, K., Goodman, R. L., Tilbrook, A. J., Ubuka, T., et al. (2008) · Endocrinology · doi:10.1210/en.2008-0581 · Cited by 387
Kirby, E. D., Geraghty, A. C., Ubuka, T., Bentley, G. E., & Kaufer, D. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901176106 · Cited by 379
Herbison, A. E. (2008) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.05.006 · Cited by 351 · cited 3×
“Endocrinology, April 2010, 151(4):1902–1913 endo.”
BackgroundInfluentialDucret, E., Anderson, G. M., & Herbison, A. E. (2009) · Endocrinology · doi:10.1210/en.2008-1623 · Cited by 295
Anderson, G. M., Relf, H.-L., Rizwan, M. Z., & Evans, J. J. (2009) · Endocrinology · doi:10.1210/en.2008-1359 · Cited by 157
Cited by
Kisspeptins and Reproduction: Physiological Roles and Regulatory Mechanisms
Pinilla, L., Aguilar, E., Dieguez, C., Millar, R. P., & Tena-Sempere, M. (2012) · Physiological Reviews · doi:10.1152/physrev.00037.2010 · Cited by 801
Self-citationThe Lipophilic Bullet Hits the Targets: Medicinal Chemistry of Adamantane Derivatives
Wanka, L., Iqbal, K., & Schreiner, P. R. (2013) · Chemical Reviews · doi:10.1021/cr100264t · Cited by 696
Tsutsui, K., Bentley, G. E., Bedecarrats, G., Osugi, T., Ubuka, T., & Kriegsfeld, L. J. (2010) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2010.03.001 · Cited by 280
Khan, A. R., & Kauffman, A. S. (2012) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2011.02162.x · Cited by 99
Knockdown of hypothalamic RFRP3 prevents chronic stress-induced infertility and embryo resorption
Geraghty, A. C., Muroy, S. E., Zhao, S., Bentley, G. E., Kriegsfeld, L. J., & Kaufer, D. (2015) · eLife · doi:10.7554/elife.04316 · Cited by 87
“There is some debate as to whether RFRP3 is a hypophysiotropic hormone (Murakami et al., 2008; Kirby et al., 2009; Pineda et al., 2010a, 2010b) or only centrally inhibits GnRH to elicit a response (Rizwan et al., 2009, 2012).”
Background
Metadata
- Authors
- Pineda, R., Garcia-Galiano, D., Sanchez-Garrido, M. A., Romero, M., Ruiz-Pino, F., Aguilar, E., Dijcks, F. A., Blomenröhr, M., Pinilla, L., van Noort, P. I., & Tena-Sempere, M.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2010-02-16
- Volume
- 151
- Issue
- 4
- Pages
- 1902-1913
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2116285899
- Cited by
- 95
- References
- 7
- FWCI
- 11.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.